STIM — Neuronetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Neuronetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	49	94.1	70.3	59.7	18.5
Net Total Accounts Receivable
Net Total Receivables	9.05	9.98	15.4	18.7	24.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	65	115	98.8	93.8	58.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.35	5.1	5.32	4.78	33.3
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	78.7	141	117	116	141
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.7	15.7	33.2	19.8	31.3
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	53.2	56	59.8	81.6	113
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	25.5	85.2	57.1	34.2	27.7
Total Liabilities & Shareholders' Equity	78.7	141	117	116	141
Total Common Shares Outstanding